Sophie Ramsay Selected Research

6-fluoro-6-desoxyoxymorphone (FOXY)

6/2020

A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sophie Ramsay Research Topics

Disease

4	Overactive Urinary Bladder (Overactive Bladder) 06/2022 - 03/2016
1	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 01/2017
1	Pelvic Organ Prolapse 08/2016
1	Prolapse 08/2016

Drug/Important Bio-Agent (IBA)

1	oxybutynin (Tavor)FDA LinkGeneric 06/2020
1	fesoterodine FDA Link 06/2020
1	6-fluoro-6-desoxyoxymorphone (FOXY)IBA 06/2020
1	Muscarinic AntagonistsIBA 08/2017
1	Hyaluronic Acid (Hyaluronan)IBA 01/2017
1	dextranomerIBA 01/2017
1	polyacrylamideIBA 01/2017
1	HydrogelsIBA 01/2017

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 06/2022
1	Hysterectomy 08/2016
1	Pessaries 08/2016
1	Therapeutics 03/2016